Hepatic Lesion of Mucosa-Associated Lymphoid Tissue Lymphoma Revealed by Al18F-NOTA-FAPI-04 PET/CT

Ying Kou; Zhiwei Yao; Zhuzhong Cheng

doi:10.1097/RLU.0000000000003863

Hepatic Lesion of Mucosa-Associated Lymphoid Tissue Lymphoma Revealed by Al18F-NOTA-FAPI-04 PET/CT

Clin Nucl Med. 2022 Jan 1;47(1):e49-e51. doi: 10.1097/RLU.0000000000003863.

Authors

Ying Kou¹, Zhiwei Yao², Zhuzhong Cheng¹

Affiliations

¹ From the The PET/CT Center, Department of Nuclear Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China.
² Department of Orthopedics, the People's Hospital of Chengdu Tianfu New Area, Chengdu, Sichuan, China.

PMID: 34392285
DOI: 10.1097/RLU.0000000000003863

Abstract

A middle-aged man was newly diagnosed with mucosa-associated lymphoid tissue lymphoma with secondary liver involvement. The hepatic lesion was not shown on FDG PET/CT but FAPI (fibroblast-activated protein inhibitor) PET/CT, which revealed abnormal FAPI accumulation. This case demonstrated that FAPI PET/CT might provide value in hepatic mucosa-associated lymphoid tissue lymphoma.

MeSH terms

Fluorodeoxyglucose F18
Heterocyclic Compounds, 1-Ring
Humans
Lymphoma, B-Cell, Marginal Zone* / diagnostic imaging
Male
Middle Aged
Positron Emission Tomography Computed Tomography*
Quinolines

Substances

68Ga-FAPI
Heterocyclic Compounds, 1-Ring
Quinolines
Fluorodeoxyglucose F18
1,4,7-triazacyclononane-N,N',N''-triacetic acid